Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of long-acting recombinant human FSH injection in women undergoing ART
CTR20231567Phase 3Completed
- Sponsor
- China Resources Double-Crane Pharmaceutical
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of corifollitropin alfa in female infertility, sponsored by China Resources Double-Crane Pharmaceutical. Started May 2023; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on CTR20231567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231567.